Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection

por Clancy, J P, Dupont, L, Konstan, M W, Billings, J, Fustik, S, Goss, C H, Lymp, J, Minic, P, Quittner, A L, Rubenstein, R C, Young, K R, Saiman, L, Burns, J L, Govan, J R W, Ramsey, B, Gupta, R
Publicado 2013

P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study

por McClenaghan, E., Cosgriff, R., Brownlee, K., Ahern, S., Burgel, P.-R., Byrnes, C.A., Colombo, C., Corvol, H., Cheng, S.Y., Daneau, G., Elbert, A., Faro, A., Goss, C.H., Gulmans, V., Gutierrez, H., de Monestrol, I., Jung, A., Nährlich, L., Kashirskaya, N., Marshall, B.C., McKone, E., Middleton, P.G., Mondejar-Lopez, P., Pastor-Vivero, M.D., Padoan, R., Rizvi, S., Ruseckaite, R., Salvatore, M., Stephenson, A.L., da Silva Filho, L.V.R., Melo, J., Zampoli, M., Abdrakhmanov, O., Harutyunyan, S., Carr, S.B.
Publicado 2021